In McCain, Obama Dueling Health Care Plans, Will ETFs Emerge the Winner?
August 21, 2008 – Our national health care problem has become one focus of the presidential campaign, and in the long run, it could benefit exchange traded funds (ETFs). In this competitive global economy, lay-offs, restructurings, downsizing, and reengineering -... Continue Reading »

Genentech Holds Out for Better Offer, Which Could Deliver a Boost to Biotech ETFs
August 14, 2008 – Biotechnology stocks and exchange traded funds (ETFs) could get a shot in the arm, as Genentech (DNA) rejected a takeover bid from Roche, which they feel has undervalued the company. Roche, the Swiss pharmaceutical company, offered... Continue Reading »

Five ETFs That Have Beared The Current Market
August 5, 2008 – Anyone who follows the markets knows that while some exchange traded funds (ETFs) might be down, other areas and ETFs are heading in the other direction. In our current bear market, there have bee several ETFs... Continue Reading »

Biotech ETFs Are a Matter of Personal Choice
July 27, 2008 – Biotechnology appeals to many investors, and with four different exchange traded funds (ETFs) focused on the class, is there a fund that is better than the rest? The sector is one of the few non-commodity related... Continue Reading »

Tom Lydon Talks Biotech ETFs on CNBC’s Power Lunch
July 22, 2008 – Tom Lydon talked about biotechnology exchange traded funds (ETFs) on CNBC this afternoon. Video of Tom’s segment is below: Continue Reading »

Biotechnology ETFs Growing…Like Genetically Modified Crops?
July 16, 2008 – Biotechnology is the non-commodity exchange traded fund (ETF) area du jour, it seems. In a time where the markets seem bleak, the sector is delivering a ray of light. Genentech (DNA) this week upped its 2008... Continue Reading »

Can Biotech And Agriculture ETFs Get Acreage With Your Money?
July 10, 2008 – Not many exchange traded funds (ETFs) outside those focused on commodities are perched above their 200-day moving averages. That makes it worth noting that two biotechnology ETFs crossed the mark recently. Both iShares Nasdaq Biotechnology (IBB)... Continue Reading »

UN Food Conference Goes Bananas; Can ETFs Help?
June 8, 2008 – > The three-day conference held by the United Nations Food and Agriculture Organization went bananas to say the least, and didn’t do much to help solve the root of the problem; but that didn’t hurt... Continue Reading »

Dynamic Duos of ETFs
June 4, 2008 – Batman and Robin, Laurel and Hardy, Chick and Stu, the list of dynamic duos goes on, so how about biotech and agriculture, within the realm of exchange traded fund (ETF) investors? Biotechnology is believed to... Continue Reading »

Clean Energy, Health Care ETFs Looking for Revival
May 22, 2008 – Two exchange traded funds (ETFs) representing two different sectors - health care and clean energy - had a slow, rough start for the first part of 2008. These funds probably want to put those days... Continue Reading »

HOLDRs: Do They Have A Hold On You?
May 21, 2008 – HOLDRs, or Holding Company Depositary Receipts, are one of the most popularly traded exchange traded funds (ETFs) on the American Stock Exchange on any given day. However, the HOLDRs are not technically ETFs. They... Continue Reading »

Biotech ETFs Could Get A Shot In The Arm From Acquisition
May 10, 2008 – Biotechnology is rising up to analyst’s predictions that a near future run could send related stocks and exchange traded funds (ETFs) up. The latest April announcement that Takeda Pharmaceutical would buy Massachusetts-based Millennium Pharmaceuticals... Continue Reading »

A View of ETFs In An Obama White House
May 4, 2008 – If Barack Obama were to win the election for presidency this November, what would happen to the investment world, particularly exchange traded fund (ETF) investors? Awhile back, we talked about funds that could benefit in... Continue Reading »

Biotech Sector And ETFs Suffer Failed Study
April 30, 2008 – The biotechnology sector suffered after a Genetech Inc. (DNA) study regarding treatment of Lupus failed, letting down related exchange traded funds (ETFs). The study of Rituxan was in the later stages, reports Wanfeng Zhou for Thomson... Continue Reading »

Be Part Of The Solution With A Biotech ETF
April 20, 2008 – The best approach to being involved with the advent of a breakthrough medicine, or a cure for cancer, as an investor, would be to consider a biotech-focused exchange traded fund (ETF). The most impressive... Continue Reading »

A Rise In Prescription Costs May Take ETFs Up, Too
April 15, 2008 – The problem of expensive health care may soon cut into people who are fully insured, as health insurance companies adopt a new pricing system, sending focused stocks and exchange traded funds (ETFs) into more... Continue Reading »

Health Care Revenues, ETFs At The Mercy Of Presidential Candidates
April 11, 2008 – Health care exchange traded funds (ETFs) are non-discretionary, have a projected growth rate at 6.6%-6.7% from 2008 through 2017. It could also get a boost from specific reforms, if those reforms come to pass.... Continue Reading »

Health Care ETFs Looking A Little Wan
March 14, 2008 –   How healthy are exchange traded funds (ETFs) focused on the medical world for your portfolio? Many of the ETFs from this field have experienced the ups and downs of the broader market of late... Continue Reading »

Defense, Biotechnology ETFs Stand to Gain if McCain Wins
February 8, 2008 – The events of Super Tuesday didn’t solidify much in the way of the presidential race on the Democratic side, but one person has taken a few guesses as to which exchange traded funds (ETFs)... Continue Reading »

Biotechnology ETFs Raise Hopes On Stock Jump
February 8, 2008 – Biotechnology exchange traded funds (ETFs) and stocks are thriving as fourth quarter earnings from Biogen Idec Inc. (BIIB) gave investors an 84% jump in profit. According to the Associated Press, Biogen’s profits rose on... Continue Reading »

ETF Bargain Hunters Start Searching
February 4, 2008 – Bargain shoppers may have their time cut out for them, as many exchange traded funds (ETFs) are touting low price-to-earnings ratios (P/E Ratios). The P/E Ratio is a valuation of a company’s current share price... Continue Reading »

Use Caution With Biotechnology ETFs
January 14, 2008 – Sometimes, not all sector exchange traded funds (ETFs) are alike. It pays to do your homework, because although there are often several funds covering an area, performance can vary greatly. Alan Brochstein of Seeking Alpha... Continue Reading »

M&A Helping Biotech ETF
December 14, 2007 – Biotech stocks and related exchange traded funds (ETFs) tend to take a downward slide once excessive risk enters into the market. Biotech ETFs, have held there own over the past few months, as iShares... Continue Reading »

Variations in Biotechnology ETFs
October 12, 2007 – We’ve mentioned before that not all exchange traded funds (ETFs) that cover a specific region or sector are created equal. Even if the stocks are similar, ETFs can behave differently. In funds weighted by market... Continue Reading »

ETFs in the Biotech Environment
September 16, 2007 – There has been mixed news on biotech stocks and exchange traded funds (ETFs) this year.  Large-cap biotech has been hurt by concerns on drug safety, tightened Medicare reimbursement and new competition from generics, reports Karen... Continue Reading »

Boomers Could Help Future of Health and Biotechnology ETFs
September 13, 2007 – Investing in biotechnology and health-related exchange traded funds (ETFs) would seem to make sense as the baby boomer generation ages. An increase in older citizens creates more demand for health care services with the... Continue Reading »

Health Care and Biotech ETFs Remain Healthy through Market Volatility
August 13, 2007 – Even with rough markets last week, there were some exchange traded funds (ETFs) that ended on a positive note. Some were the narrowly-focused health care ETFs, HealthShares Autoimmune-Inflammation (HHA) and HealthShares Metabolic-Endocrine (HHM), which... Continue Reading »

Biotech ETFs - What Happened?
July 20, 2007 – Could it be time to invest in a biotech-focused exchange traded fund (ETF)? Some say this was supposed to be the biotech century, where innovation was to lead to efficient, sustainable energy and gene-based... Continue Reading »

Biotech ETFs Healthy on R&D
April 24, 2007 – The biotech industry, and the exchange traded funds (ETFs) that track them have had a strong year. The SPDR S&P Biotech Fund (XBI) was up 11.2% last month, reports Joanne Von Alroth for Investor’s... Continue Reading »

HealthShares ETFs To Launch Tuesday
January 22, 2007 – A unique family of exchange traded funds (ETFs) are expected to launch Tuesday, January 23rd on the New York Stock Exchange. The HealthShares focus is to allow individuals and investors to narrowly choose where... Continue Reading »

Biotech ETF (IBB) Adds Diversity While Big Pharma Feels Congressional Pressure
January 17, 2007 – Pharmaceutical companies are feeling pressure from Congress to lower the price of drugs for Americans. Even though this has had a slightly negative effect on bigger pharmaceutical companies, biotechnology stocks in general look strong.... Continue Reading »

Biotechnology ETFs Just Getting Started
January 6, 2007 – Biotech focused exchange traded funds (ETFs) could soon be effected by the upcoming success of Monsanto (MON), a crop biotech company.  Carey Gillam of Reuters reports the company’s research and development is accelerating at... Continue Reading »